TMSP(SH:600671)2025-10-28 09:35Financial Performance - The company's operating revenue for the third quarter was ¥55,343,038.75, a decrease of 15.03% compared to the same period last year[4]. - The total profit for the quarter was ¥2,882,447.89, reflecting a significant decline of 83.76% year-over-year[4]. - The net profit attributable to shareholders was ¥3,960,987.86, down 73.25% from the previous year[4]. - Basic earnings per share were ¥0.03, a decrease of 72.94% compared to the same period last year[5]. - Total operating revenue for the first three quarters of 2025 reached ¥158,940,412.66, a 27.5% increase from ¥124,680,446.71 in the same period of 2024[22]. - Operating profit for the first three quarters of 2025 was ¥7,153,523.96, compared to an operating loss of ¥7,305,559.19 in the first three quarters of 2024[22]. - Net profit for the first three quarters of 2025 was ¥7,508,073.79, a significant recovery from a net loss of ¥3,761,066.17 in the same period of 2024[23]. - The company reported a basic and diluted earnings per share of ¥0.1167 for the first three quarters of 2025, recovering from a loss of ¥0.0303 per share in the same period of 2024[23]. - The total comprehensive income attributable to the parent company for the first three quarters of 2025 was ¥14,208,796.60, compared to a loss of ¥3,695,546.06 in the same period of 2024[23]. Cash Flow - The cash flow from operating activities was negative at -¥19,958,994.53, indicating cash outflows during the quarter[4]. - Cash flow from operating activities showed a net outflow of ¥30,831,088.80 in the first three quarters of 2025, an improvement from a net outflow of ¥38,957,059.21 in the same period of 2024[25]. - Cash flow from investing activities resulted in a net outflow of ¥26,636,693.31 for the first three quarters of 2025, compared to a net outflow of ¥18,571,079.09 in the same period of 2024[26]. - Cash flow from financing activities generated a net inflow of ¥16,102,282.69 in the first three quarters of 2025, contrasting with a net outflow of ¥25,932,182.68 in the same period of 2024[26]. - The company's cash and cash equivalents were RMB 11,740,346.34, down from RMB 65,724,985.87 at the end of 2024[16]. - The company’s cash and cash equivalents at the end of the first three quarters of 2025 stood at ¥6,098,492.05, down from ¥14,502,291.44 at the end of the same period in 2024[26]. Assets and Liabilities - Total assets at the end of the reporting period were ¥429,727,307.20, a decrease of 2.66% from the end of the previous year[5]. - The net assets attributable to shareholders increased by 27.12% to ¥66,592,681.40 compared to the previous year-end[5]. - The company's total current assets amounted to RMB 220,539,380.50, a slight decrease from RMB 222,713,693.72 at the end of 2024[16]. - Total liabilities decreased to RMB 335,430,332.10 from RMB 356,444,336.38, a reduction of approximately 5.9%[18]. - The company's total equity increased to RMB 94,296,975.10 from RMB 85,018,901.31, representing a growth of about 10.4%[18]. - Non-current liabilities due within one year decreased by 4.102 million due to lease payments and the termination of lease agreements[9]. Receivables and Inventory - The company reported a significant increase in accounts receivable by 58.26%, primarily due to increases from subsidiaries[8]. - Accounts receivable increased to RMB 152,820,152.54 from RMB 96,565,118.72 at the end of 2024, indicating a growth of approximately 58.4%[16]. - Inventory decreased to RMB 41,498,781.04 from RMB 52,323,040.59, reflecting a decline of about 20.7%[16]. - Other receivables decreased by 710,000 compared to the end of last year, totaling -34.79 million[9]. - Other current assets increased by 2.4 million compared to the end of last year, totaling 121.88 million[9]. - Construction in progress increased by 11.96 million compared to the end of last year, totaling 957.40 million[9]. Expenses and Losses - Non-operating income and expenses resulted in a net loss of -¥1,018,712.99 for the period[7]. - Sales expenses increased by 1.27 million compared to the same period last year, totaling 127.68 million[10]. - Investment income decreased by 8.615 million due to the absence of related matters this year[9]. - Asset impairment losses increased by 6.2351 million compared to the same period last year[9]. - The company reported a net loss of RMB 242,155,533.95 in retained earnings as of September 30, 2025, compared to a loss of RMB 256,364,330.55 at the end of 2024[18]. Corporate Developments - The company established a wholly-owned subsidiary, Qingdao Simulation Medical Center, with a registered capital of RMB 3 million[14]. - The company wrote off inventory with a book value of RMB 3,092,147.88, including a provision for impairment of RMB 628,850.52[14]. Accounting Standards - The company has not adopted new accounting standards or interpretations that would affect the financial statements for the year of first implementation[27].